RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carlos Jiménez to Prednisone

This is a "connection" page, showing publications Carlos Jiménez has written about Prednisone.
Connection Strength

0.208
  1. L?pez-Oliva MO, P?rez-Flores I, Molina M, Jos? Aladr?n M, Trujillo H, Redondo-Pach?n D, L?pez V, Facundo C, Villanego F, Rodr?guez M, Carmen Ruiz M, Ant?n P, Rivas-Oural A, Cabello S, Portol?s J, de la Vara L, Tabernero G, Valero R, Galeano C, Moral E, Ventura A, Coca A, ?ngel Mu?oz M, Hern?ndez-Gallego R, Shabaka A, Ledesma G, Bouarich H, ?ngeles Rodr?guez M, P?rez Tamaj?n L, Cruzado L, Emilio S?nchez J, Jim?nez C. Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry. Nefrologia (Engl Ed). 2023 Jul-Aug; 43(4):442-451.
    View in: PubMed
    Score: 0.208
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support